Aprea Therapeutics Inc (APRE)

Dec 11, 2025

Insider Buying: John Hamill Acquires Additional Shares of Aprea Therapeutics Inc (APRE) - GuruFocus

Dec 11, 2025

Dec 11, 2025

Aprea therapeutics director Duey Marc buys $25,000 in shares By Investing.com - Investing.com Canada

Dec 11, 2025

Dec 11, 2025

Hamill, Sr. VP at Aprea Therapeutics, buys $5,825 in stock - Investing.com India

Dec 11, 2025

Dec 11, 2025

Hamill, Sr. VP at Aprea Therapeutics, buys $5,825 in stock By Investing.com - Investing.com Nigeria

Dec 11, 2025

Dec 11, 2025

Hamill, Aprea Therapeutics CFO, buys $5,825 in stock - Investing.com

Dec 11, 2025

Dec 09, 2025

Aprea Therapeutics, Inc. announced that it expects to receive $3.055822 million in funding - marketscreener.com

Dec 09, 2025

Dec 09, 2025

Aprea Therapeutics raises $3.1 million in private placement - Investing.com

Dec 09, 2025

Dec 09, 2025

Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times

Dec 09, 2025

Dec 09, 2025

Aprea Therapeutics (Nasdaq: APRE) prices $3.1M private placement to extend cash runway into Q1 2027 - Stock Titan

Dec 09, 2025

Dec 08, 2025

Aprea Therapeutics (NASDAQ: APRE) registers 219,242 shares under 2019 equity plan - Stock Titan

Dec 08, 2025

Dec 03, 2025

Why Aprea Therapeutics Inc. stock is seen as undervaluedMarket Weekly Review & Growth Focused Investment Plans - Newser

Dec 03, 2025

Dec 03, 2025

Aprea Therapeutics, Inc. (NASDAQ:APRE): Is Breakeven Near? - simplywall.st

Dec 03, 2025

Dec 02, 2025

How Aprea Therapeutics Inc. stock performs in rising dollar environmentJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser

Dec 02, 2025

Dec 01, 2025

Head and Neck Cancer Therapeutics Market | Global Market Analysis Report2035 - Fact.MR

Dec 01, 2025

Nov 28, 2025

Why Aprea Therapeutics Inc. stock could rally in 20252025 Top Decliners & Stepwise Swing Trade Plans - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Is Aprea Therapeutics Inc a good long term investmentRSI Overbought/Oversold & Learn From the Strategies of Institutions - earlytimes.in

Nov 27, 2025

Nov 26, 2025

Aprea Therapeutics Strengthens Patent Portfolio to Advance Oncology Innovation - MSN

Nov 26, 2025

Nov 21, 2025

Aprea Advances Dual DDR Programs as Early Signals of Drug Activity Strengthen - MSN

Nov 21, 2025

Nov 21, 2025

Why Aprea Therapeutics Inc. stock could outperform in 2025July 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 21, 2025

Nov 21, 2025

Can Aprea Therapeutics Inc. stock sustain free cash flow growthWatch List & Weekly Momentum Picks - newser.com

Nov 21, 2025

Nov 20, 2025

How supply chain issues affect Aprea Therapeutics Inc. stockEarnings Overview Report & Weekly Watchlist of Top Performers - newser.com

Nov 20, 2025

Nov 20, 2025

Is Aprea Therapeutics Inc. stock a top momentum play2025 Macro Impact & Free Daily Entry Point Trade Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Tools to assess Aprea Therapeutics Inc.’s risk profileQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com

Nov 20, 2025

Nov 19, 2025

Will Aprea Therapeutics Inc. stock outperform value stocks2025 Valuation Update & Weekly High Return Opportunities - newser.com

Nov 19, 2025

Nov 18, 2025

Aprea Therapeutics (Nasdaq: APRE) Advances Cancer Pipeline as Maxim Group Sets $10 Price Target - Barchart.com

Nov 18, 2025

Nov 17, 2025

Is Aprea Therapeutics Inc. stock attractive after correction2025 Big Picture & Fast Gaining Stock Reports - newser.com

Nov 17, 2025

Nov 16, 2025

Is Aprea Therapeutics Inc. stock poised for growthJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com

Nov 16, 2025